SOURCES AND EFFECTS OF REACTIVE OXYGEN INTERMEDIATES IN THE BRAIN
大脑中活性氧中间体的来源和作用
基本信息
- 批准号:6111826
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Del Rio Hortega in 1919 was the first person to
recognize the importance of microglia. They are the brain
macrophages or phagocytes, which also release reactive oxygen
species. Their function is to get rid of unwanted cellular debris and
also to kill invading microorganisms. An oxygen burst is generated
by the hexose monophosphatase shunt producing the superoxide
anion by the NADPH oxidase at the membrane. Phorbol myristate
acetate (PMA) acts directly on this mechanism. We investigated the
effect of beta amyloid (A-beta) on the production of superoxide
anion of activated microglia. A-beta (1-40) is derived from the
amyloid precursor protein, which contains about 700 amino acids.
The cysteine rich section contains a site which can reduce cupric
ions to cuprous ions. A-beta has an extracellular domain as well as
a membrane domain. We experimented on activated hamster
microglia and human monocyte derived macrophages with PMA,
and found that additional exposure to A-beta (1-40) produced only
a small quantity of superoxide anion. However, when the microglia
were primed or pretreated with A-beta followed by PMA
activation, there was a larger increase in superoxide anion
production. Without PMA, the superoxide production was reduced
to the value obtained in the presence of A-beta (1-40), which was
greater than the non-primed and non-stimulated case. The
conclusion is that there is another site responsible for the
superoxide production. Perhaps this site is the mitochondrion. In
Alzheimer's disease, A-beta (1-40) is located in the plaque
periphery, where it causes the resting microglia found in plaques to
produce damaging reactive oxygen species, which can attack the
most vulnerable part of the nervous system, the synapses. Microglia
are not able to destroy the plaques because they are composed of
beta pleated sheets, which are only soluble in formic acid.
1919年,Del bbbbo Hortega是第一个
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DANIEL L GILBERT其他文献
DANIEL L GILBERT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DANIEL L GILBERT', 18)}}的其他基金
SOURCES AND EFFECTS OF REACTIVE OXYGEN INTERMEDIATES IN THE BRAIN
大脑中活性氧中间体的来源和作用
- 批准号:
6290617 - 财政年份:
- 资助金额:
-- - 项目类别:
相似海外基金
Developing multitarget enzyme inhibitors as safe and effective anti-migraine treatments
开发多靶点酶抑制剂作为安全有效的抗偏头痛治疗方法
- 批准号:
10714658 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Novel Enzyme Inhibitors in the Innate Immune Evasion Repertoire of Staphylococci
葡萄球菌先天免疫逃避库中的新型酶抑制剂
- 批准号:
10395608 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Novel Enzyme Inhibitors in the Innate Immune Evasion Repertoire of Staphylococci
葡萄球菌先天免疫逃避库中的新型酶抑制剂
- 批准号:
10576908 - 财政年份:2021
- 资助金额:
-- - 项目类别:
The Development and Study of Novel Lipopeptide Antibiotics and Enzyme Inhibitors
新型脂肽抗生素和酶抑制剂的开发与研究
- 批准号:
RGPIN-2017-04233 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Discovery Grants Program - Individual
Novel Enzyme Inhibitors in the Innate Immune Evasion Repertoire of Staphylococci
葡萄球菌先天免疫逃避库中的新型酶抑制剂
- 批准号:
10166534 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Novel Enzyme Inhibitors in the Immune Evasion Repertoire of Staphylococcus aureus (Equipment Supplement)
金黄色葡萄球菌免疫逃逸的新型酶抑制剂(设备补充)
- 批准号:
10796329 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Utility of Centrally Acting Angiotensin Converting Enzyme Inhibitors to slow the progression of Dementia
中枢作用血管紧张素转换酶抑制剂减缓痴呆进展的效用
- 批准号:
10259832 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Utility of Centrally Acting Angiotensin Converting Enzyme Inhibitors to slow the progression of Dementia
中枢作用血管紧张素转换酶抑制剂减缓痴呆进展的效用
- 批准号:
10642850 - 财政年份:2020
- 资助金额:
-- - 项目类别:
The Development and Study of Novel Lipopeptide Antibiotics and Enzyme Inhibitors
新型脂肽抗生素和酶抑制剂的开发与研究
- 批准号:
RGPIN-2017-04233 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Discovery Grants Program - Individual
Utility of Centrally Acting Angiotensin Converting Enzyme Inhibitors to slow the progression of Dementia
中枢作用血管紧张素转换酶抑制剂减缓痴呆进展的效用
- 批准号:
10408178 - 财政年份:2020
- 资助金额:
-- - 项目类别: